May 24, 2023

G7 Cancer is launched

Apr. 19, 2023

World-first confirmation of standard treatment for RAS wild-type colorectal cancer－Paper published in JAMA－

Apr. 12, 2023

Start of Clinical Research of the First Japanese-Produced Next-Generation Photon Counting Computed Tomography

Apr. 10, 2023

Efficacy of Anti-HER2 Therapy with Trastuzumab Deluxecan in Uterine Carcinosarcoma Consistent with PDX-model predictions of efficacy, paving the way for the development of treatments for rare cancers.

Apr. 3, 2023

A clinical trial of Tazemetostat for pediatric and AYA patients with malignant tumors which have no standard treatment or which is refractory to standard treatment using Patient-Proposed Healthcare Service (NCCH2214/ TURTLE trial) to improve drug access for pediatric and AYA patients with refractory tumors.